Bionano Genomics Inc. (BNGO)
NASDAQ · Healthcare
Bionano Genomics Inc. EBITDA 2017–2025
Bionano Genomics Inc. annual/quarterly ebitda history and growth rate from 2017 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Bionano Genomics Inc. ebitda for the quarter ending March 31, 2026 was -5.6 M, a 7.36% decrease year-over-year.
- Bionano Genomics Inc. ebitda for the twelve months ending March 31, 2026 was -74.4 M, a 39.51% increase year-over-year.
- Bionano Genomics Inc. annual ebitda for 2025 was -23.8 M, a 73.53% decrease from 2024.
- Bionano Genomics Inc. annual ebitda for 2024 was -90.0 M, a 55.36% decrease from 2023.
- Bionano Genomics Inc. annual ebitda for 2023 was -201.5 M, a 65.09% increase from 2022.
- Bionano Genomics Inc. annual ebitda for 2022 was -122.1 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bionano Genomics Inc. EBITDA — FAQ
Bionano Genomics Inc. (BNGO) ebitda over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BNGO's ebitda history?
The chart and table above show Bionano Genomics Inc.'s ebitda by year and by quarter, including the growth rate.